Details for 2019151152
Up to date per 04.04.2026
Actions
Details for 2019151152
Granted/Registered
European Patent
04.09.2019 A
15.03.2023 B1
20.03.2012
US
201261613173 P
10.07.2012
US
201261669889 P
02.08.2012
US
201261678715 P
A61K 31/4184 20060101AFI20190614BHEP
Owner
Eagle Pharmaceuticals, Inc.50 Tice Boulevard Suite 315 Woodcliff Lake, NJ 07677US
Representative
Representative
Haffner und Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT
Inventor
SUNDARAM, Srikanth138 Emerson Road Somerset, NJ 08873US
TARRIFF, Scott, L.28 Tudor Rose Terrace Mahwah, NJ 07430US
Information about Fees